Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion

Patients with multiple myeloma (MM) are typically of an advanced age and may have significant co-existing medical conditions. They have often had multiple lines of therapy and as such experience disease-related effects alongside associated treatment toxicities. Daratumumab is a monoclonal antibody a...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Tracy, Jagger, Jacqueline, Wood, Jodie, Woodrow, Carmel, Snowden, Alicia, Haines, Sally, Crosbie, Christina, Houdyk, Kristen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Consensus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996585/
https://www.ncbi.nlm.nih.gov/pubmed/29963589
http://dx.doi.org/10.4103/apjon.apjon_9_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996585/
https://www.ncbi.nlm.nih.gov/pubmed/29963589
http://dx.doi.org/10.4103/apjon.apjon_9_18

Ejemplares similares